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Detection of developmental phenotypes in zebrafish embryos typically involves a 18 
visual assessment and scoring of morphological features by an individual 19 
researcher. Subjective scoring could impact results and be of particular concern 20 
when phenotypic effect patterns are also used as a diagnostic tool to classify 21 
compounds. Here we introduce a quantitative morphometric approach based on 22 
image analysis of zebrafish embryos. A software called FishInspector was developed 23 
to detect morphological features from images collected using an automated system 24 
to position zebrafish embryos. The analysis was verified and compared with visual 25 
assessments of three participating laboratories using three known developmental 26 
toxicants (methotrexate, dexamethasone and topiramate) and two negative 27 
compounds (loratadine and glibenclamide). The quantitative approach exhibited 28 
higher sensitivity and made it possible to compare patterns of effects with the 29 
potential to establish a grouping and classification of developmental toxicants. Our 30 
approach improves the robustness of phenotype scoring and reliability of assay 31 
performance and, hence, is anticipated to improve the predictivity of developmental 32 
toxicity screening using the zebrafish embryo.  33 
Keywords: developmental toxicity, zebrafish embryo, alternatives to animal testing, 34 
image analysis 35 
36 































































1. Introduction 37 
Zebrafish (Danio rerio) exhibit 70-80% gene sequence homology with humans and 38 
share structural similarities with vertebrates (Gunnarsson et al., 2008; Dooley and 39 
Zon, 2000). Therefore, their embryos are used as an alternative model for 40 
developmental toxicity screening of drugs and chemicals (Brannen et al., 2010; 41 
Selderslaghs et al., 2009). The possibility of holistic assessment in a small-scale 42 
system, the ability to produce large numbers of progeny, and the transparency of the 43 
embryos and their rapid development have made the model particularly attractive 44 
and led to the development of high-throughput assays (Truong et al., 2014; Padilla et 45 
al., 2012).  46 
Results from small-scale pilot studies have demonstrated a high concordance 47 
between zebrafish and mammalian developmental toxicity with an overall 48 
concordance of 72-92% (Brannen et al., 2010; Selderslaghs et al., 2009; Van den 49 
Bulck et al., 2011; Hermsen et al., 2011; Krupp, 2016). However, in inter-laboratory 50 
variability studies (Gustafson et al., 2012; Ball et al., 2014), some inconsistencies 51 
with respect to concordance analysis were also observed. The concordance of 52 
individual laboratories for developmental toxicity or teratogenic classification ranged 53 
between 60% and 70% when compared to mammalian data, but only 5 of 20 54 
compounds were similarly classified (i.e. teratogenic or non-teratogenic) by all four 55 
participating laboratories (Gustafson et al., 2012). In a subsequent study with 37 56 
compounds and two laboratories, a concordance of 71% for teratogen classification 57 
was observed (Ball et al., 2014). This variability between laboratories may have been 58 
partly caused by the visual observation and classification of developmental 59 
alterations by an individual technician or researcher and limited standardization. 60 































































Hence, the approach currently used for developmental toxicity screening in zebrafish 61 
embryos might be biased by the experience and accuracy of the observer. 62 
Furthermore, observations are often not documented by storing the relevant images, 63 
thus making verification and reanalysis of data difficult.  64 
Previous phenotypic image analyses have focused on fluorescent imaging for 65 
measuring e.g. cardiovascular development (Leet et al., 2014), cardiovascular 66 
function (Leet et al., 2014; Letamendia et al., 2012; Yozzo et al., 2013; Burns et al., 67 
2005) and angiogenesis (Letamendia et al., 2012; Vogt et al., 2009). There are few 68 
published studies using automatic phenotypic image analysis for bright-field 69 
microscope images without fluorescent markers or staining (Deal et al., 2016; 70 
Jeanray et al., 2015; Liu et al., 2012; Schutera et al., 2016; Arslanova et al., 2010). 71 
Some of these studies were limited to the identification of specific phenotypes such 72 
as lethality (Liu et al., 2012; Alshut et al., 2010), hatching status (Liu et al., 2012), 73 
changes in pigmentation (Schutera et al., 2016; Arslanova et al., 2010) or lack of 74 
eyes (Schutera et al., 2016). One study aimed at developing a computational 75 
malformation index through the use of morphometric parameters (e.g. total body 76 
area, convexity) in combination with a very brief human visual assessment (Deal et 77 
al., 2016). That method was more objective as user-scoring was based on 78 
microscopic observations and the cumulative degree of abnormality could be 79 
described, but the different phenotypes (e.g. edema, small eyes) were not resolved. 80 
A different approach was developed by Jeanray et al. (2015) using supervised 81 
machine learning to identify developmental phenotypes. This approach is based on 82 
an initial expert classification of phenotypes and requires several rounds of 83 
classification and learning but can be used to establish concentration response 84 
curves for cumulative phenotypic assessment.  However, the same or similar 85 































































instrumentation and settings would be required to apply their established models 86 
directly.  87 
Crucial for a quantitative, unbiased approach to phenotype assessment using 2-D 88 
images is a proper orientation of the fish embryos. Slight differences in the 89 
orientation and the subsequent 2-D projection could lead to changes in feature 90 
detection. Therefore, in this study, an image-based detection and quantification of 91 
morphological features in zebrafish embryos was developed based on an automated 92 
system for positioning of the embryos in a capillary. Multiple morphological features 93 
were automatically extracted from zebrafish images using a custom MATLAB-based 94 
software called FishInspector. While our workflow was developed for automated 95 
positioning in a capillary, it can also be applied to manually positioned embryos as 96 
conducted in other studies (e.g. Peravali et al., 2011). However, this may be more 97 
time consuming and may introduce additional variability.  In a second step, we used 98 
the analytical platform KNIME and R scripts for morphometric analysis and 99 
quantification using the coordinates of each feature detected by FishInspector.  100 
Morphological features were complemented by video-based measurements of heart 101 
rate and behavioral effects (locomotor response at 96 hours post-fertilization). These 102 
two functional parameters provide further endpoints relevant for safety areas 103 
assessment and potentially linked to developmental toxicity. For instance, a 104 
comparative endpoint analysis (Ducharme et al., 2013) has revealed a high 105 
correlation of behavioral endpoints with (gross) malformations of fish embryos and 106 
hence may support quantitation of overall assessment of teratogenic effects.  107 
To demonstrate the capacity of the software for the multi-endpoint analysis, it was 108 
applied to a set of five model compounds representing diverse drug classes. Three 109 































































compounds (methotrexate, topiramate and dexamethasone) known to cause 110 
developmental toxicity in mammals and two compounds (glibenclamide and 111 
loratadine) as non-developmental toxicants. The performance of this method was 112 
also analyzed in the context of sensitivity differences between three laboratories 113 
experienced with conventional visual assessment and scoring of developmental 114 
anomalies in the zebrafish embryo. The intention was, for example, to understand 115 
whether the automatic assessment provides increased sensitivity compared to 116 
conventional assessments in other laboratories. 117 
2. Material and methods 118 
2.1. Chemicals  119 
The following chemicals were used: loratadine (CAS-RN 79794-75-5, purity ≥ 98%, 120 
Sigma-Aldrich), metothrexate (CAS-RN 59-05-2, purity ≥ 98.5%, AppliChem), 121 
glibenclamide (CAS-RN 10238-21-8, purity ≥ 99%, Sigma-Aldrich), dexamethasone 122 
(CAS-RN 50-02-2, purity ≥ 97%, Fluka) , topiramate CAS-RN 97240-79-4, purity ≥ 123 
98%, Sigma-Aldrich), all-trans retinoic acid (CAS-RN 302-79-4, purity≥ 98%, 124 
AppliChem Panreac) and N-phenylthiourea (PTU, CAS-RN 103-85-5,purity ≥ 98%, 125 
Sigma–Aldrich). Loratadine, glibenclamide, dexamethasonse and all-trans retinoic 126 
acid were dissolved in dimethyl sulfoxide (DMSO). Test solutions were obtained by 127 
dilution of the stock solutions in embryo test medium according to the OECD testing 128 
guideline 236 (OECD, 2013 pH=7.4-7.5) resulting in final DMSO concentrations of 129 
0.01% (all-trans retinoic acid), 0.5% (loratadine and glibenclamide), 1% 130 
(dexamethasone). The different DMSO concentrations reflect the different solubility 131 
in DMSO, i.e. the concentration of DMSO was kept as low as possible to obtain full 132 
concentration response curves for mortality and sublethal phenotypes.  133 































































2.2. Zebrafish developmental toxicity assay overview 134 
Adult, healthy, unexposed zebrafish were used for the production of fertilized eggs. 135 
We used the UFZ-OBI strain (generation F14-15), obtained originally from a local 136 
breeder and kept for several generations at the UFZ. Fish were cultured and used 137 
according to German and European animal protection standards and approved by 138 
the Government of Saxony, Landesdirektion Leipzig, Germany (Aktenzeichen 75-139 
9185.64). Just after fertilization eggs were treated against fungal infection with a 140 
diluted Chloramine-T bleaching solution (0.5% w/v) for 60s with gentle periodic 141 
agitation, washed twice with embryo medium and transferred into a petri dish for egg 142 
selection. Bleaching did not affect the hatching of embryos at later stages. All control 143 
embryos were hatched at 96 hours post-fertilization (hpf). The bleaching was 144 
conducted to avoid carry over of fungi or microbes from the tanks. Embryos were 145 
exposed to the test compound, a solvent control and a positive control (all-trans 146 
retinoic acid at 12.5 nM) from 2 hpf to 48hpf and from 2hpf to 96hpf, at a 147 
temperature of 28 (±1)°C (14:10 light:dark cycle). Forty eight-hour exposures were 148 
conducted in crystallization dishes covered with watchmaker glasses with a test 149 
volume of 16 mL and 16 embryos per dish. Ninety six-hour exposures were 150 
conducted in rectangular 96-well microplates (Clear Polystyrene, flat bottom, 151 
Uniplate®, Whatman™, GE Healthcare, Little Chalfont, UK) covered by a lid with a 152 
test volume of 400 µL (one embryo per well, 16 wells per concentration tested). No 153 
evaporation was observed during the exposure period. The different protocols were 154 
used since manual dechorionation is difficult to conduct in 96-well plates.  For 155 
hydrophobic compounds (logP>4) low exposure volumes in 96-well microplates (400 156 
µL exposure volume per embryo) may result in a (pronounced) decline in exposure 157 
concentration when compared to exposure in crystallization dishes (1000 µL volume 158 































































per embryo). Therefore, for hydrophobic compounds (loratadine and glibenclamide) 159 
exposure was conducted in crystallization dishes for both the 48 and 96 hour 160 
exposure in order to compensate for a potential loss of exposure concentration due 161 
to absorption in embryos and to the wells of the microplate. Tests were performed 162 
with at least two replicates. Renewal of the exposure solutions were performed every 163 
24h, except for methotrexate, for which, due to confirmation of stable exposure 164 
concentration, a 48h renewal interval was selected (see supplementary table S2), 165 
and for topiramate, for which stability was assumed (Micheel et al., 1998) and no 166 
renewal was done.  Phenotypic assessment by automated imaging (section 2.4) was 167 
conducted after assessment of lethality, behavioral effects (at 96 hpf) and visual 168 
assessment using a stereomicroscope (Olympus SZX10, MA, USA). Visual and 169 
automatic image-based assessment of phenotypes at the UFZ was conducted for 170 
the same experiment and same fish. Supplementary table S1 shows the endpoints 171 
evaluated by visual observation. More details on the test protocol can be found in the 172 
supplementary file (Table S2). 173 
2.3.  Developmental staging analysis 174 
Comparison of developmental stages of zebrafish incubated at 28 (±1)°C was done 175 
using untreated embryos from 5 different stages from 32 to 96 hpf (32, 48, 72, 82 176 
and 96 hpf). Linear regression analysis was performed to determine which of the 177 
features quantified using the FishInspector exhibit a significant correlation during 178 
normal development.   179 
2.4. Image-based quantification of morphological features  180 
2.4.1. Automated imaging of zebrafish embryos 181 































































Images of zebrafish embryos were obtained using the VAST Bioimager (Union 182 
Biometrica, Gees, Belgium) (Pulak, 2016; Pardo-Martin et al., 2010) using the on-183 
board camera with 10 µm resolution. Beforehand imaging embryos were 184 
dechorionated (required for 48 hpf stages only) and anesthetized with a tricaine 185 
solution (150mg/L, TRIS 26mM, pH 7.5). Embryos exposed in crystallization dishes 186 
were transferred to a 96-well microplate with rectangular wells. Loading of each fish 187 
from rectangular 96-well plates was done using the LP sampler (Union Biometrica, 188 
Gees, Belgium) and four pictures were automatically collected (two laterals, one 189 
dorsal and one ventral image). Additionally, a video of 15 seconds at 30 frames per 190 
second was recorded of each embryo in lateral position for later video-based 191 
determination of the heart frequency. For the analysis, fish embryos were removed 192 
from the microtiter plates such that individuals from different concentrations were 193 
analyzed alternately. This was done to avoid time bias. The concentration of tricaine 194 
used here has been shown not to affect the heart rate frequency within the time 195 
frame (2 h) that was used for analysis (Yozzo et al., 2013). 196 
2.4.2. Feature detection using the FishInspector software 197 
Lateral control images of embryos at 48 hpf and 96 hpf were used initially for 198 
software development. FishInspector was developed within MATLAB® environment 199 
and the source code and an executable version for windows operation system is 200 
freely available (last updated version is available via Zenodo (Kießling et al., 2018)). 201 
The detection of the various features is organized hierarchically, i.e. in order to 202 
locate a certain feature the locations of previously detected features are included. 203 
For example, detection of the contour of the embryo is guided by the capillary 204 
boundaries, since the embryo definitely will be located inside the capillary. 205 
Subsequently, other features are identified in a stepwise manner (Supplementary 206 































































Figure S1). Hence, the detection of specific morphological features is dependent on 207 
the detection of other features and is facilitated by excluding regions that may 208 
interfere. The identification of the regions of interest was driven by visual observation 209 
and measurement of generic object properties. For example, once the contour of the 210 
fish was localized, the eye was detected by searching for a dark object either in the 211 
right or left half of the zebrafish. The detection algorithms were successively 212 
improved by using images of embryos treated with all-trans retinoic acid (used as the 213 
positive control for gross changes in body morphology). Given that establishment of 214 
a 100 % correct automated feature detection would be very challenging and to allow 215 
improvement by the user, the software permits modification of the parameters used 216 
for the automated feature detection, and also manual correction if the feature is not 217 
sufficiently detected. At present, jaw morphology analysis cannot be detected 218 
automatically with the FishInspector and requires a manual annotation step, i.e. label 219 
of the tip of the lower part of the mouth. The resulting output of the FishInspector is a 220 
set of xy coordinates of the morphological feature detected. For each image 221 
analyzed, data are exported to a single JSON file, which is a language-independent 222 
open-standard file format typically used for transmitting data between applications. 223 
The boundary coordinates of multiple detected features can then be stored in a 224 
structured text file. This allows the seamless integration of the FishInspector output 225 
into custom post-processing algorithms, which can be implemented in any 226 
programming language. 227 
2.4.3. Quantification of phenotypic features 228 
The JSON data files were used as input in a customized KNIME workflow with R 229 
scripts (Berthold et al., 2008, R core Team 2017).  The phenotypic features analyzed 230 
are described in Table 1. Shape information (mainly length and surface area) was 231 































































extracted using the “Momocs” R package (Bonhomme et al., 2013; Claude et al., 232 
2008). For extraction of the fish tail curvature, only the notochord coordinates from 233 
the tail of the fish were considered (Supplementary Figure S2). Curvatures along the 234 
tail were calculated by extracting from the smoothed notochord line the value of the 235 
second derivative when the first derivative is 0. The maximum curvature value along 236 
the tail was used for the analysis. Tail curvature was calculated using R with the 237 
package “features” (Varadhan, 2015) using as smoother the function “smooth.spline” 238 
with a spar value of 0.9. Head size was quantified by drawing a line between the eye 239 
and otolith centroid, then an angle was taken from the otolith to the upper contour of 240 
the fish, also from the eye to the bottom contour of the fish to enclose the head 241 
region (See supplementary Figure S3). Lower jaw position was evaluated at 96 hpf 242 
by using the manual selection on the FishInspector. To quantify the effects, the 243 
distance in the x coordinate between the eye centroid and the lower jaw tip was 244 
calculated using the KNIME workflow (See supplementary Figure S4).  245 
Application of the workflow does not require knowledge of computer programing 246 
languages. The complete workflow only requires the use of the standard open 247 
source tools (KNIME, R and ImageJ. The workflow is provided in Dryad, Teixido et 248 
al., 2018). Pigmentation was quantified by measuring the sum area of pigment cells 249 
along the lateral line, using the area covered by the notochord as the enclosure 250 
region. In order to validate the pigmentation analysis, embryos were exposed to 251 
increasing concentrations (0-150µM) of N-phenylthiourea (PTU) (Supplementary 252 
Figure S5), a model compound that is known to inhibit melanization (Karlsson et al., 253 
2001).     254 
2.5. Heart rate quantification 255 































































An automated image workflow was developed using the KNIME Analytics Platform 256 
(workflow available in Dryad, Teixido et al., 2018). The zebrafish heart as the region 257 
of interest (ROI) is detected by comparing the absolute difference in pixel intensity 258 
between two consecutive frames. By using a threshold method and morphological 259 
operations, irrelevant areas were removed from the analysis. Then the pixel 260 
variance of the ROI in each frame was used to determine the heart frequency using 261 
a Fast Fourier transform with the spectrum function included in the base package of 262 
R.  263 
2.6. Locomotor response (LMR) 264 
The locomotor response was assessed at 96 hpf prior to the analysis with the VAST 265 
Bioimager system. Embryonic movement was tracked using the ZebraBox video 266 
tracking system (Viewpoint, Lyon, France) for 40 minutes in a series of light and dark 267 
periods to stimulate movement (10 min equilibration in light, followed by 20 min in 268 
dark and a final 10 min light phase) as described in Irons et al. (2010). The 269 
movement in the light periods was recorded using maximum intensity (1200 lux). 270 
Movement in light and dark periods was recorded using an infrared camera and the 271 
video tracking mode with a detection threshold set to 20. The temperature was 272 
continuously maintained at 28(±1) °C. Live embryos, including malformed embryos 273 
and embryos showing no inflation of the swim bladder, were considered for the 274 
analysis of the locomotor response. The percentage of effects (EC50) was calculated 275 
on the basis of the mean travelled distance as described in Klüver et al. (2015) using 276 
the dark phase interval (10-20min).  277 
2.7. Inter-laboratory study design  278 































































Three laboratories participated in this study. These were: Department of 279 
Bioanalytical Ecotoxicology, Helmholtz Center for Environmental Research (UFZ), 280 
R&D Preclinical Safety, Sanofi-Aventis Deutschland GmbH and BBD BioPhenix-281 
Biobide. The laboratories used an agreed test protocol (described in section 2.2) 282 
with minor differences between laboratories as shown in supplementary table S2. 283 
The UFZ was the only laboratory to include an image-based quantification of 284 
morphological features using the FishInspector (as described in section 2.4), heart 285 
rate quantification (section 2.5) and behavior analysis (section 2.6). Testing of the 286 
compounds was done in a blind manner at two of the three laboratories (Biobide and 287 
UFZ), i.e. identity of the compounds was only released after completion of the effect 288 
assessment.  The test concentrations were not harmonized between the different 289 
labs and were individually adjusted based on range findings or to improve the 290 
description of the concentration response curves in replicates. 291 
2.8. Data evaluation 292 
Two approaches were used for the concentration-response analysis: a) effect 293 
quantification with continuous data normalized to the mean control value and, b) 294 
threshold-based quantal effect data. The first approach was used for endpoints with 295 
high variability between controls of replicates, observed for heart rate, behavior and 296 
pigmentation. For these endpoints, data were normalized to the mean control of 297 
each replicate and concentration-response curves were derived from these data. For 298 
all other endpoints (eye size, body length, yolk sac size, head size, swim bladder, 299 
jaw-eye distance and otolith-eye distance), similar to the method proposed for 300 
obtaining benchmark responses with dichotomized continuous data (EPA 2012), a 301 
threshold value was established by analysis of the variability of about 130 control 302 
embryos of different replicates (Supplementary table S3). Values deviating by ± 2 303 































































SD were considered as indicating a deviation from the control and were used to 304 
calculate the fraction of embryos for which the appropriate endpoint was affected. 305 
For the overall cumulative effect assessment, a threshold of 2.5 SD was used given 306 
the higher likelihood that one of the features was affected randomly. Concentration-307 
response curves were derived for all the morphological features and also for lethality 308 
and abnormalities (visual assessment) only when a clear concentration-response 309 
was observed and more than 30% of embryos were affected. To characterize 310 
responses for each chemical we derived an EC50 as the concentration at which 50 311 
percent of the embryos were deviating from the feature as it was observed in 312 
controls.  Lethal concentrations (LC50) and effect concentrations (EC50) for each 313 
endpoint were obtained with the sigmoidal dose−response (Hill-slope) equation (eq. 314 







    (1) 316 
Constraints for max and min were set to 100 and 0. 317 
In order to rank the capability of an agent to produce developmental toxicity in 318 
relation to lethal effects we calculated the teratogenic index (TI), which is defined as 319 
the ratio between the LC50/EC50 and was successfully established in the Xenopus 320 
frog embryo’s developmental toxicity screening assay (Mouche et al., 2017). A 321 
chemical was classified as developmentally toxic if the teratogenic index was greater 322 
than 1.2 in either developmental stage based on previous internal results obtained in 323 
the Sanofi lab (data not shown). If no mortality was observed, the chemical was 324 
considered developmentally toxic if morphological alterations were concentration-325 
dependent reaching more than the 30% effect level. For the automatic image-based 326 
assessment, effect concentrations (EC50) for all endpoints were calculated based on 327 































































a log-logistic model in R (LL.4 model from package drc (Ritz et al., 2015)). To reduce 328 
uncertainty, treatment groups with less than 4 surviving individuals were excluded 329 
from the analysis. Effect signatures of visual and image-based assessment were 330 
obtained by normalizing each effect concentration to the most sensitive feature (EC50 331 
most sensitive feature/EC50 specific feature) for each time point (48hpf and 96hpf). 332 
This allows for comparison of all features at the same scale. Hierarchical clustering 333 
was performed based on the “Manhattan” distance using the hclust function in R and 334 
“Ward.D2” method. 335 
3. Results 336 
3.1. The FishInspector software and phenotype characterization 337 
A user-friendly platform for feature detection based on two-dimensional projection of 338 
fish embryos called FishInspector was developed. The graphical user interface of the 339 
software is illustrated in Figure 1. FishInspector is written in MATLAB® and an 340 
executable version for Windows is freely available (latest software update available 341 
at Zenodo (Kießling et al., 2018)). The software has a modular structure and the 342 
MATLAB® code can, in principle, be extended to include more features by 343 
programming appropriate plugins. In order to compensate for potential errors of the 344 
automated image analysis, particularly during the development of the software or in 345 
cases where it is difficult to establish error-free automated detection, the software 346 
allows user interaction and correction. Variability of image qualities depending on the 347 
source (camera and microscope settings, resolution, contrast, intensity) may impact 348 
on feature detection. Therefore, adjustable parameters were included in the 349 
software, making it possible to compensate for camera or microscope dependent 350 
differences. In its current version the FishInspector is able to locate up to 10 different 351 































































morphological features (Table 1), and export their coordinates to an open format 352 
(JSON - JavaScript Object Notation - file). The average processing time was 3h per 353 
plate (2h unsupervised for the image acquisition and 1h for the FishInspector 354 
analysis). It should be noted that FishInspector is not intended to detect deviations 355 
from normal phenotypes. This is done by subsequent analysis using the identified 356 
feature coordinates and existing analysis routines. The identified feature coordinates 357 
are processed subsequently in a KNIME workflow to derive their metrics (Table 1, 358 
see Material and methods, supplementary KNIME workflow in Dryad, Teixido et al., 359 
2018). The features were chosen because of their relevance in zebrafish embryo 360 
development and the observed phenotypes of the model compound exposures.  361 
Some features can be expected to change during the course of development. So, 362 
developmental retardation would lead to changes in those parameters in particular.. 363 
If several features that correlate during the course of normal development change in 364 
a consistent manner, this could serve as an indicator for developmental retardation. 365 
Therefore, cross-correlation of the different features was analyzed in untreated 366 
embryos from 32 to 96 hours post-fertilization (hpf) (Figure 2b). Body length and eye 367 
size were the most highly correlated features (r= 0.94 and 0.87, respectively) 368 
following by yolk sac size (r= -0.84). The eye-ear distance, a common morphological 369 
marker used to stage zebrafish embryos (Kimmel et al., 1995; Beasley et al., 2012), 370 
showed a slight correlation (r=0.7). However, if restricted to stages between 48 hpf 371 
and 96 hpf the correlation increased (r=0.92, supplementary Figure S6) and was 372 
therefore used to asses growth retardation at 96 hpf. The lower jaw position was 373 
analyzed between 72 hpf and 96 hpf and also showed a positive correlation 374 
(Supplementary Figure S7). 375 































































In fish embryo toxicity assays, DMSO is often used as carrier solvent to accelerate 376 
solubilization of hydrophobic chemicals, up to concentrations of around 1 %. 377 
Therefore, effects of DMSO were also evaluated using the FishInspector software 378 
and KNIME workflows. Most of the affected endpoints exhibited EC50 ≥2% (v/v) 379 
DMSO, except for non-inflation of the swim bladder and locomotor response. Both 380 
showed an EC50 value of around 1% DMSO (Supplementary table S4) representing 381 
the maximum solvent concentration that was used for analyzing the effects of 382 
dexamethasone (for loratadine, glibenclamide and all-trans retinoic maximum DMSO 383 
concentrations of 0.5 %, 0.5% and 0.01%, respectively, were used).  384 
3.2. Comparison of the automated quantitative versus visual analysis 385 
To illustrate the performance of the software we analyzed the phenotypic effects of 386 
six model compounds previously characterized in the zebrafish and mammalian 387 
models for developmental toxicity (Supplementary table S5). Firstly, the visual 388 
assessment and the automated quantitative assessment with the FishInspector were 389 
compared by calculating a cumulative EC50 representing the concentration where 390 
50% of the embryos were affected by any of the quantified individual endpoints 391 
(swim bladder effects were excluded for this analysis). The two assessments 392 
revealed very similar effect levels (Figure 3a). However, the visual assessment did 393 
not reach an EC50 for dexamethasone, while the automated assessment – based 394 
mainly on morphological changes of pericard size, yolk sac size and lower jaw 395 
position – was able to reveal an EC50 of 5 µM after 96 h of exposure.  396 
EC50 values were also derived for each individual endpoint analyzed with the visual 397 
and automatic image-based method (See Figure 3b for an example of concentration-398 
response curve).  399 































































Figure 3c shows the comparison between visual and image-based specific altered 400 
endpoints using a color scale that represents the EC50 normalized to the most 401 
sensitive endpoint for each of the time points (48 hpf and 96 hpf). 402 
In addition to the morphological endpoints analyzed with the FishInspector, two 403 
functional endpoints, heart rate and locomotor response for behavior analysis, were 404 
added to our analysis to increase the diagnostic power of the phenotype 405 
assessment. Loratadine showed a strong reduction in heart rate at both 406 
measurement time points. Topiramate exposure was found to alter heart rate at 96 407 
hpf. Methotrexate and all-trans retinoic acid showed reduced locomotion in the dark 408 
phase, in contrast to topiramate and loratadine, which showed increased locomotion 409 
during light phase.  410 
3.3. Chemical signatures 411 
The measurement of each individual endpoint enabled the construction of a 412 
phenotypic signature for each compound according to the most affected endpoint. 413 
Figure 4 shows these signatures with a color code scaled from no effect (yellow, 0) 414 
to specific effect (red, 1).  415 
3.4. Inter-laboratory assessment of the zebrafish developmental toxicity 416 
assay 417 
The five selected compounds were also evaluated in two other laboratories that are 418 
currently using visual assessment to score for developmental toxic effect in zebrafish 419 
(Sanofi and Biobide).The overall results (LC50, EC50 values) are shown in table 2.  420 
Only in one laboratory (Sanofi), dexamethasone showed a concentration-dependent 421 
increase in effects and an EC50 could be extrapolated. Based on the teratogenic 422 
index with individually set laboratory thresholds (Sanofi threshold for developmental 423 
toxicity liability of TI>1.2) there were four compounds classified as developmentally 424 































































toxic compounds (loratadine, methotrexate, topiramate and dexamethasone) and 425 
one (glibenclamide) classified as non-developmentally toxic. Glibenclamide is not 426 
reported to cause developmental toxicity in mammals.      427 
4. Discussion 428 
4.1. The FishInspector as a flexible platform for detecting morphological 429 
features 430 
Although large-scale toxicity screens have been carried out with zebrafish (Truong et 431 
al., 2014; Padilla et al., 2012; Gustafson et al., 2012), the phenotypic assessments 432 
are typically non-quantitative or semi-quantitative at best. Morphological phenotyping 433 
remains a subjective process that may vary greatly between laboratories and could 434 
be affected by the fatigue, training and expertise of those who perform the analysis 435 
and scoring.  The use of a more unbiased, quantitative phenotypic assessment using 436 
image analysis, such as the one presented in this manuscript, can mitigate the 437 
subjectivity inherent in tests that rely on phenotype observations. Aiming to reduce 438 
this potential subjective bias from zebrafish embryo morphological analysis and to 439 
potentially link phenotype patterns to mode of action in subsequent analyses, we 440 
developed the software FishInspector. It provides an integrated and user-friendly 441 
platform for feature detection based on a two-dimensional projection of fish embryos. 442 
A crucial prerequisite is that embryos are analyzed out of their chorion (requiring 443 
manual dechorionation for stages < 72 hpf) and that images are obtained after 444 
precise orientation of embryos. For instance, a more than 75% eye overlap of the left 445 
and right eye in lateral two-dimensional projections was reported to be required for 446 
ear-eye distance analyses with less than 5% error (Beasley et al., 2012).  447 































































Correction of feature detection with the FishInspector is frequently required, but not 448 
for all features. For example, eye size, body length, notochord, and yolk are robust 449 
parameters that rarely need interaction or require only little correction. Other features 450 
like the jaw or pericard mostly require user correction. However, user interaction in 451 
the FishInspector is required only for the detection of the features and can also be 452 
conducted blind. Assessment of whether the chemical is provoking a certain 453 
phenotype or deviation from controls is made via concentrations-response modelling. 454 
This greatly reduces the bias if compared to visual microscopic observation and 455 
scoring.  Furthermore, with the FishInspector one has an improved documentation of 456 
the analysis given that assessments can always be traced back to the original 457 
images. 458 
Existing image analysis platforms (Molecular Devices ImageXpress, Definiens® 459 
Developer software, Noldus Danioscope™, Thermo Scientific Cellomics® Zebrabox 460 
or GE Healthcare Lifesciences Cell Investigator Zebrafish Analysis) do not at present 461 
allow feature annotation to the same extent or with the same flexibility or future 462 
development potential as our approach. Moreover they are not freely available as 463 
open source software, and some of them require co-purchase of certain equipment 464 
and/or have been discontinued. The FishInspector software in our study has been 465 
used in conjunction with the VAST bioimager system which automatically positions 466 
embryos in a glass capillary prior to imaging (Pardo-Martin et al., 2010). However, in 467 
principle, it is possible to use conventional pictures obtained with a bright-field 468 
microscope (Supplementary figure S8). Therefore, we provide a simple workflow that 469 
automatically rotates the images and draws a virtual capillary. The user-friendly 470 
workflow processes multiple images simultaneously based on an imageJ macro 471 
embedded in a KNIME workflow (Teixido et al., 2018). Hence, it uses established 472 































































and open source software. The workflow can easily be adapted to accommodate 473 
different image properties depending on the source of the image (e.g. intensity, 474 
contrast). As for any type of image analysis, the quality of the images is critical even 475 
if manually positioned embryo images are used.  476 
A limited number of features can be detected at present (Table 1). Due to the 477 
modular architecture of the FishInspector, the plan is to increase the number of 478 
detected morphological features, including support for dorsal and ventral images. 479 
Future versions may also implement self-learning algorithms to make automatic 480 
feature detection more robust. Manually approved feature contours could be used, 481 
for example, to train Active Shape/Appearance models (Cootes et al., 1998; Cootes 482 
and Taylor, 1992) and to minimize the need for manual correction.  483 
Cross-correlation analysis of all the features with progressing development indicated 484 
that a sub-set of the morphological endpoints exhibit a high correlation and enable 485 
improved identification of growth retardation (Figure 2b), a common parameter 486 
evaluated in mammalian developmental toxicity studies. The potential confounding 487 
effects of DMSO on phenotypes and behavior was also revealed in this study. 488 
DMSO was used up to a concentration of 1%, representing the EC50 for non-swim 489 
bladder inflation and reduced locomotor activity. Effects of DMSO on locomotion 490 
have been previously reported in other studies at a concentration as low as 0.01% 491 
(Chen et al., 2011). The effect on these parameters should be carefully interpreted 492 
(e.g. reduce locomotion in dexamethasone-treated embryos in combination with 1% 493 
DMSO in our study). Hence, we suggest, in general, minimizing the amount of 494 
DMSO especially for specific examinations or considering potential interference by 495 
solvents in the interpretation of results. However, for screening purposes, 496 
maximization of the compound solubility and uptake through standardized DMSO 497 































































concentrations (e.g. 1%) have been used effectively with good predictivity (Krupp, 498 
2016).  499 
4.2. Software performance and differences between visual and automated 500 
assessment 501 
The ability of our approach to detect developmental toxicity was demonstrated by 502 
using six compounds previously assessed by other laboratories for the optimization 503 
and performance evaluation of the zebrafish developmental toxicity assay 504 
(Gustafson et al., 2012). Our image-based quantitative approach eliminates possible 505 
observation bias while demonstrating consistency with the overall effect assessment 506 
by visual analysis of an experienced researcher. Furthermore, automated 507 
assessment included the evaluation of two additional endpoints, body length and 508 
pigmentation, which could not be properly evaluated by visual analysis due to its 509 
inherent subjectivity. Our approach slightly increases throughput given that the 510 
imaging is conducted unsupervised. However, the amount of data generated also 511 
increases the subsequent analysis workload. Indeed we did not primarily aim or 512 
expect to increase throughput, rather to increase content and accuracy in the 513 
morphological assessment.  514 
Comparison between visual and automatic specific altered endpoints reveals in 515 
general good agreement, with three major exceptions (Figure 3c): (1) Methotrexate 516 
exposure resulted in increased incidence of embryos showing bending of the tail 517 
after 48 h of exposure. However the visual analysis was not sensitive enough to 518 
capture this effect. (2) Using visual assessment we were only able to observe a 519 
concentration-dependent effect on swim bladder inflation for dexamethasone after 520 
96h of exposure, but the automatic assessment revealed also a concentration-521 
dependent increase of pericard size, reduction of yolk sac size and reduced jaw-eye 522 































































distance. (3) For loratadine exposure after 96 h, the visual assessment indicated 523 
swim bladder inflation and growth retardation as the most sensitive endpoints. 524 
However, the measurement of body length revealed that loratadine specifically 525 
affects body length of the embryo at much lower concentrations than other indicators 526 
of growth retardation. Failure to inflate the swim bladder at 96 hpf represented the 527 
most sensitive endpoint in almost all the chemical exposures and could be related to 528 
a developmental delay as untreated embryos at 96 hpf often do not have a fully 529 
inflated swim bladder (Supplementary figure S9). The swim bladder in the 530 
developing zebrafish has been shown to be evolutionarily homologous to the 531 
mammalian lung (Zheng et al., 2011). However, it is not known whether swim 532 
bladder malformations could relate to developmental toxicity in higher vertebrates. 533 
Moreover, swim bladder development depends on blood circulation and, hence, may 534 
represent a secondary effect of disturbed vascularization (Yue et al., 2015). 535 
Chemicals affecting heart rate (e.g. β-blockers, Bittner et al., 2018) displayed a co-536 
occurrence of missing swim bladder inflation and heart rate decrease. Therefore, as 537 
swim bladder inflation seems to be affected by many chemicals, it may have a 538 
limited diagnostic value at the 96 hpf stage. Two functional endpoints, heart rate and 539 
locomotor response, allowed us to discover potential off-target effects of drugs, like 540 
reduced heart rate after loratadine exposure. Heart and jaw abnormalities are 541 
frequently analyzed as teratogenic indicators, using transgenic or stained fish 542 
embryos. Heart morphology has not yet been included in the automatic assessment 543 
with the FishInspector, but heart rate quantification may partially capture heart 544 
malformations.  545 
4.3. Comparative effect analysis 546 































































Using the different morphological and functional endpoints quantified in our study, 547 
phenotypic signatures were derived for each chemical and scaled by normalization 548 
to the effect concentration of the most sensitive endpoint. Our data suggests that 549 
observed differences in phenotype patterns could reflect the differences in the 550 
underlying mechanism of action (Figure 4). Using the FishInspector software, a 551 
larger amount of chemicals with similar mechanisms could now be analyzed to 552 
reveal whether commonalities between compound effect patterns could be derived 553 
and linked to modes of action or common key events. In the present analysis, 554 
embryos exposed to all-trans retinoic acid and methotrexate both showed tail or 555 
body axis curvature as the most sensitive morphological feature. Both compounds 556 
are associated with neural tube defects in mammals. All-trans retinoic acid interferes 557 
with the retinoic pathway, which is especially important for anterior-posterior 558 
patterning of the spinal cord and hindbrain, neuronal differentiation and axis 559 
elongation (Tonk et al., 2015). Methotrexate is a folate analog that acts by 560 
competitively inhibiting dihydrofolate reductase, an enzyme involved in DNA 561 
biosynthesis. This impairment in nucleotide biosynthesis can decrease mitotic rates 562 
during critical morphogenetic windows (Lee et al., 2012).  Hence, similarities in effect 563 
patterns may reflect the conversion of both pathways at neural tube organogenesis.  564 
Our study also supports evidence for the known side-effects of the antihistaminic 565 
loratadine. The most affected endpoint for loratidine exposure was reduced heart 566 
rate and body length of the embryos. Some antihistaminic compounds have been 567 
shown to reduce the heart rate by competitive inhibition of the muscarinic receptors 568 
in mammals (Liu et al., 2006). In zebrafish, knock-down of muscarinic receptors has 569 
been demonstrated to alter cardiac β-adrenergic receptor activity (Steele et al., 570 
2009).  571 































































The phenotypic effect observed after exposure to the antiepileptic drug topiramate 572 
revealed growth retardation as the most affected endpoint after 48h and 96 h 573 
exposure. The use of antiepileptic drugs during pregnancy has been associated with 574 
congenital defects and developmental delay in humans (Campbell et al., 2013), 575 
however the underlying mechanism is still unknown. Our approach allowed us to 576 
identify growth retardation as the main endpoint of topiramate exposure, rather than 577 
teratogenic effects. Antiepileptic drugs are also capable of inducing 578 
neurodevelopmental effects (Ornoy, 2006) and interfere with the GABA and 579 
AMPA/kainate glutamate receptor and block voltage-dependent sodium channels 580 
(Schneiderman, 1998). In our study we observed increased locomotion during the 581 
light phase of the locomotor response analysis, which may potentially relate to the 582 
MoA of topiramate.   583 
Dexamethasone exposure caused reduced yolk sac size in zebrafish embryos, 584 
potentially related to the role of glucocorticoid in energy metabolism by mobilizing 585 
and relocating energy substrate stores (Nesan and Vijayan, 2013). Mammalian 586 
studies have demonstrated that glucocorticoids cause cleft palate and some studies 587 
have shown that glucocorticoids alter craniofacial development in zebrafish as well 588 
(Hillegass et al., 2008). Our study also revealed an alteration in jaw development by 589 
a reduced jaw-eye distance (Figure 3c). 590 
4.4. Inter-laboratory assessment 591 
The performance of our method was verified by comparing it with the visual 592 
assessments of three different laboratories experienced with conventional visual 593 
assessment of the zebrafish embryos. A previous inter-laboratory assessment study 594 
showed that technical differences were the primary contributor to inter-laboratory 595 
differences in classification of a compound as developmentally toxic using zebrafish 596 































































embryos (Ball et al., 2014). Our approach avoids score assignment based on 597 
qualitative measures of effect. The inter-laboratory study showed good agreement; 598 
however dexamethasone was classified as developmentally toxic by only one 599 
laboratory (Sanofi) using the visual inspection method. The quantitative approach 600 
showed a higher sensitivity for the detection of chemical effects and the sensitivity of 601 
effect assessment for dexamethasone was increased (Table 2). The overall weak 602 
effects caused by dexamethasone, however, could also be due to reduced 603 
bioavailability of the compound. It has been reported that embryonic concentrations 604 
reached only 20 % of the exposure concentrations indicating a potential slow uptake 605 
and internal concentration not in equilibrium (Steenbergen et al., 2017). Uptake of 606 
the chemicals by zebrafish embryos was not analyzed in our study, as the focus was 607 
on feature detection and quantification of developmental toxicity. However, we 608 
consider it important that this be included in routine screens, either via appropriate 609 
TK models or by internal concentration analysis (Brox et al., 2014) since a slow 610 
and/or limited uptake of a substance by an embryo could represent a confounding 611 
factor in the assessment of effects. Loratadine was classified as a false-positive in all 612 
laboratories including the automatic image-based assessment. This compound 613 
demonstrated a high uptake in previous studies, which may have contributed to the 614 
false positive results in the assay (Gustafson et al., 2012). Whether analysis with the 615 
FishInspector would lead to a higher number of false positives, however, requires a 616 
more thorough analysis of a greater number of chemicals.  617 
5. Conclusions 618 
This study has demonstrated the value of the FishInspector software and 619 
quantitative analysis has been demonstrated. The FishInspector software allows an 620 































































unbiased and automated quantitative assessment of morphological changes in 621 
zebrafish embryos after chemical treatment, particularly for embryos positioned to a 622 
precise orientation. Its modular architecture allows users to implement the detection 623 
of additional features.  Furthermore, to facilitate automatic recognition of features 624 
and reduce user interaction, self-learning algorithms for feature detection could be 625 
considered.. 626 
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Figure legends 832 
Figure 1. Screenshot of the FishInspector Graphical User Interface showing an 833 
image with detected regions of interest (ROIs) for each feature. The interface 834 
allows users to adjust and correct detected ROIs manually. The image shows 835 
the final corrected ROIs and the detected features are the following: a, lower jaw 836 
tip (orange), b, eye contour (green), c, fish contour (red), d, pericard (blue), e, 837 
yolk sac (green), f, swim bladder (blue), g, otolith (green), h, notochord (green), 838 
i, pigmentation (yellow). 839 
Figure 2. Control variability and cross-correlation of morphological features. (a) 840 
Example of distribution plot for total body length obtained for control population 841 
at 96 hpf (n=183). The mean and standard deviation (SD) were used to derive a 842 
threshold to detect the fraction of treated embryos that deviate from controls 843 
(see material and methods). (b) Cross-correlation of the morphological features 844 































































over zebrafish development (from 32 to 96 hpf). Intersections marked with blue 845 
highlighting are positively correlated and red are negative correlated. Correlation 846 
was based using the individual metric of each embryo (N=44-79). Jaw-eye 847 
distance correlation was not included as was only analyzed between 72 and 96 848 
hpf (see supplementary Figure S7). 849 
Figure 3. Comparison of quantitative versus the visual assessment of zebrafish 850 
embryo phenotypes (a) Correlation between aggregated EC50 values derived 851 
from the visual and the image-based quantitative automatic analysis. Dashed 852 
line indicates the line of unity. (b) Concentration-response curves for decreased 853 
eye size in zebrafish embryos at 96 hpf after exposure to methotrexate obtained 854 
by visual and image-based analysis. Different symbols refer to independent 855 
replicates. (c) Effect signatures obtained using visual (V) and image-based (A) 856 
assessment. The relative effects are shown by a color code from the most 857 
sensitive effect (red) to no effect (yellow). Areas in grey indicate that the 858 
endpoint was not assessed. Endpoint terminology was adapted for a better 859 
comparison, as manual analysis is a subjective measure and the automatic 860 
image-based analysis gives a quantitative measure of a detailed effect (e.g. eye 861 
abnormalities versus eye size, growth retardation versus otolith-eye distance). 862 
Glibenclamide at 48 hpf / 96hpf and dexamethasone at 48 hpf did not provoke 863 
any effects. Abbreviations: V, visual assessment; A, automatic image-based 864 
assessment using the FishInspector. ATRA, all-trans retinoic acid; LMR, 865 
locomotor response.  866 
Figure 4. Heat map of phenotypes and functional endpoints observed after chemical 867 
exposure of zebrafish embryos. The color code refers to normalized effect 868 
concentrations at the appropriate time point (48 hpf and 96 hpf). The scale 869 































































ranges from yellow (no effect) to red (most sensitive endpoints at the 870 
appropriate time point). Abbreviations: ATRA, all-trans retinoic acid. 871 
872 
































































Table 1. Morphological features measured in the zebrafish using the FishInspector 874 
software. The data are exported in Json file format and used to quantify the 875 
different metrics by the use of a customized KNIME workflow. The 876 
corresponding assessment using the conventional visual assessment is also 877 
shown in the table. 878 
Phenotypic 
feature 





in visual assessment 
Eye size Eye xy coordinates  Surface area (mm
2
) Reduced eye size 
Body length Fish contour xy coordinates  Length (mm) Not assessed 
Yolk sac size 
Yolk sac contour xy 
coordinates Surface area (mm
2
) 




Otolith xy centroid (saccule, 
the largest otolith) 
Length (mm) Not assessed 
Pericard size 
Pericard contour xy 
coordinates Surface area (mm
2
) Increased pericard size 
Tail malformations Notochord xy coordinates Curvature Tail curvature 
Swim bladder 
inflation 
Swim bladder contour xy 
coordinates Surface area (mm
2
) 
Failure to inflate the swim 
bladder 
Head size 
Fish contour xy 





Reduced or abnormal 
head size 
Pigmentation 
Area (in pixels) of pigment 
cells from lateral line 







Distance in the x coordinate 
between eye centroid and 



































































Table 2. Inter-laboratory comparison of effect concentrations, NOAEL and teratogenic index after embryo exposure to the selected 879 
compounds at 48 hpf. and 96 hpf. aPrecipitation was observed from 350 µM. b Effect concentration was extrapolated. 880 





EC50 (µM) LC50 (µM) TI (LC50/EC50) Highest tested 
concentration 48 hpf 96 hpf 48 hpf 96 hpf 48 hpf 96 hpf 
Loratadine 
V Biobide 10.78 1.64 >30 11.51 >2.8 7.1 30 µM 
V Sanofi 9.31 7.1 13.9 9.25 1.5 1.3 30 µM 
V BIOTOX-UFZ 10.34 0.65 19.14 12.82 1.8 19.7 
26 µM 
A BIOTOX-UFZ 7.9 0.38 - - 2.4 33.7 
Methotrexate 
V Biobide 337.3 216.1 >1,000 351.2 >3 1.6 1,000 µM 
V Sanofi 260 75.4 321 101 1.2 1.3 500 µM 
V BIOTOX-UFZ 244.48 184.4 357.8 304.8 1.5 1.6 
550 µM 
A BIOTOX-UFZ 247.6 90.8 - - 1.4 3.4 
Dexamethasone 
V Biobidea >300 >300 >300 >300 - - 600 µM 
V Sanofi >500 559b >500 >500 - - 500 µM 
V BIOTOX-UFZ >255 >255 >255 >255 - - 
255 µM 
A BIOTOX-UFZ >255 5 >255 >255 - >51 
Topiramate 
V Biobide 863.5 198.6 >1500 671.7 >1.7 3.4 1,500 µM 
V Sanofi 767 325 1,279 678 1.7 2.1 1,000 µM 
V BIOTOX-UFZ 551.2 284.2 1,224.1 937.9 2.2 3.2 
1,500 µM 
A BIOTOX-UFZ 311.7 58.8 - - 3.9 15.9 
Glibenclamide 
V Biobide >500 >500 >500 >500 - - 500 µM 
V Sanofi >200 >200 >200 >200 - - 200 µM 
V BIOTOX-UFZ >101.2 >101.2 >101.2 >101.2 - - 
101.2 µM 
A BIOTOX-UFZ >101.2 >101.2 >101.2 >101.2 - - 
































































































































Screenshot of the FishInspector Graphical User Interface showing an image with detected regions of interest 
(ROIs) for each feature. The interface allows users to adjust and correct detected ROIs manually. The image 
shows the final corrected ROIs and the detected features are the following: a, lower jaw tip (orange), b, eye 
contour (green), c, fish contour (red), d, pericard (blue), e, yolk sac (green), f, swim bladder (blue), g, 
otolith (green), h, notochord (green), i, pigmentation (yellow).  
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Figure 2. Control variability and cross-correlation of morphological features. (a) Example of distribution plot 
for total body length obtained for control population at 96 hpf (n=183). The mean and standard deviation 
(SD) were used to derive a threshold to detect the fraction of treated embryos that deviate from controls 
(see material and methods). (b) Cross-correlation of the morphological features over zebrafish development 
(from 32 to 96 hpf). Intersections marked with blue highlighting are positively correlated and red are 
negative correlated. Correlation was based using the individual metric of each embryo (N=44-79). Jaw-eye 
distance correlation was not included as was only analyzed between 72 and 96 hpf (see Figure S4).  
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Comparison of quantitative versus the visual assessment of zebrafish embryo phenotypes (a) Correlation 
between aggregated EC50 values derived from the visual and the image-based quantitative automatic 
analysis. Dashed line indicates the line of unity. (b) Concentration-response curves for decreased eye size in 
zebrafish embryos at 96 hpf after exposure to methotrexate obtained by visual and image-based analysis. 
Different symbols refer to independent replicates. (c) Effect signatures obtained using visual (V) and image-
based (A) assessment. The relative effects are shown by a color code from the most sensitive effect (red) to 
no effect (yellow). Areas in grey indicate that the endpoint was not assessed. Endpoint terminology was 
adapted for a better comparison, as manual analysis is a subjective measure and the automatic image-
based analysis gives a quantitative measure of a detailed effect (e.g. eye abnormalities versus eye size, 
growth retardation versus otolith-eye distance). Glibenclamide at 48 hpf / 96hpf and dexamethasone at 48 
hpf did not provoke any effects. Abbreviations: V, visual assessment; A, automatic image-based assessment 
using the FishInspector. ATRA, all-trans retinoic acid; LMR, locomotor response.  
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Heat map of phenotypes and functional endpoints observed after chemical exposure of zebrafish embryos. 
The color code refers to normalized effect concentrations at the appropriate time point (48 hpf and 96 hpf). 
The scale ranges from yellow (no effect) to red (most sensitive endpoints at the appropriate time point). 
Abbreviations: ATRA, all-trans retinoic acid.  
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